Hepatocellular Carcinoma
Showing NaN - NaN of 51
Direct Acting Antiviral-Post Authorization Safety Study
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Phoenix, Arizona
- +61 more
Jul 1, 2021
Hepatocellular Carcinoma Trial in Worldwide (Cabozantinib tablets, Placebo tablets)
Completed
- Hepatocellular Carcinoma
- Cabozantinib tablets
- Placebo tablets
-
Corona, California
- +103 more
Apr 8, 2021
Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)
Terminated
- Hepatocellular Carcinoma
- +2 more
- DEB-TACE
- Sorafenib
-
Birmingham, Alabama
- +5 more
Jan 25, 2021
Hepatocellular Carcinoma, Liver Cirrhoses Trial in Los Angeles (Pravastatin Pill, Placebo Oral Tablet)
Terminated
- Hepatocellular Carcinoma
- Liver Cirrhoses
- Pravastatin Pill
- Placebo Oral Tablet
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 31, 2020
Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and
Completed
- Cervical Cancer
- +16 more
- INCAGN02385
-
Los Angeles, California
- +3 more
Oct 28, 2020
Biomarkers for Hepatocellular Carcinoma
Completed
- Hepatocellular Carcinoma
- Hepatocellular Carcinoma Surveillance
- Blood Sample Collection
-
Los Angeles, California
- +73 more
Aug 4, 2020
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Completed
- Cirrhosis, Liver
- +3 more
-
Los Angeles, California
- +1 more
Jan 28, 2020
Hepatocellular Carcinoma Trial in Los Angeles (drug, device, biological)
Withdrawn
- Hepatocellular Carcinoma
- Perflutren Lipid Microspheres
- +5 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
May 14, 2019
Hepatocellular Carcinoma Trial in Worldwide (ThermoDox, Dummy infusion)
Completed
- Hepatocellular Carcinoma
- ThermoDox
- Dummy infusion
-
Los Angeles, California
- +60 more
Oct 23, 2018
Hepatocellular Carcinoma Trial in United States (DEB-TACE with Surefire Precision Infusion System)
Terminated
- Hepatocellular Carcinoma
- DEB-TACE with Surefire Precision Infusion System
-
Los Angeles, California
- +9 more
Sep 10, 2018
Hepatocellular Carcinoma Trial in United States (DEB-TACE)
Terminated
- Hepatocellular Carcinoma
- DEB-TACE
-
Birmingham, Alabama
- +10 more
Jun 19, 2018
Hepatocellular Carcinoma Trial in United States (IMC-A12 (cixutumumab) - 10 milligrams/kilogram (mg/kg), IMC-A12 (cixutumumab) -
Completed
- Hepatocellular Carcinoma
- IMC-A12 (cixutumumab) - 10 milligrams/kilogram (mg/kg)
- +2 more
-
Scottsdale, Arizona
- +6 more
May 1, 2018
Hepatocellular Carcinoma, Liver Cancer Trial in Los Angeles (mitomycin-c, cisplatin)
Unknown status
- Hepatocellular Carcinoma
- Liver Cancer
- mitomycin-c, cisplatin
-
Los Angeles, CaliforniaU.S.C. / Norris Comprehensive Cancer Center
May 10, 2018
Adult-to-Adult Living Donor Liver Transplantation Study
Completed
- Cirrhosis
- +2 more
-
Los Angeles, California
- +8 more
Aug 27, 2017
Hepatocellular Carcinoma Trial in Worldwide (ThermoDox, 5% Dextrose Solution)
Completed
- Hepatocellular Carcinoma
- ThermoDox
- 5% Dextrose Solution
-
Los Angeles, California
- +78 more
Mar 24, 2017
Hepatitis C Infection, Viruses, Hepatocellular Carcinoma Trial in United States (Civacir® 10%)
Completed
- Hepatitis C Infection
- +4 more
- Civacir® 10%
-
Los Angeles, California
- +22 more
Mar 14, 2017
Hepatitis C, Hepatocellular Carcinoma Trial in New Zealand, Spain, United States (Sofosbuvir, Ribavirin)
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Los Angeles, California
- +14 more
Jun 16, 2016
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Los Angeles, Pittsburgh (AFP + GM-CSF Plasmid Prime and AFP
Terminated
- Hepatocellular Carcinoma
- +13 more
- AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost
-
Los Angeles, California
- +1 more
Dec 1, 2015
Hepatocellular Carcinoma Trial in United States (Ramucirumab (IMC-1121B))
Completed
- Hepatocellular Carcinoma
- Ramucirumab (IMC-1121B)
-
Los Angeles, California
- +5 more
Sep 29, 2014
Hepatocellular Carcinoma Trial in United States (mapatumumab, sorafenib)
Completed
- Hepatocellular Carcinoma
- mapatumumab
- sorafenib
-
Los Angeles, California
- +5 more
Oct 26, 2012